Proxy Materials

Contineum Therapeutics, Inc. Filed 2026-04-30 Acc 0001628280-26-028895

Documents 1

2026-05-01 144 Sale of Securities
2026-05-01 4 Chief Scientific Officer sold 4,170 shares at an average $13.12 ($54,694)
2026-04-30 ARS Annual Report to Security Holders
2026-04-30 DEFA14A Proxy Materials
2026-04-30 DEF 14A Proxy Statement
2026-04-30 8-K Regulation FD disclosure · Other events
2025-04-29 DEFA14A Proxy Materials

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading a2026defa14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…